Skip to main content
2024 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Swati Gupta, PhD (she/her/hers)

Executive Director
AbbVie
Irvine, California

Dr. Swati Gupta is the Executive Director at AbbVie in Irvine, California, where she has been for the last 14 years. As the Strategic Advisor of Clinical Immunogenicity, she serves as an internal consultant and resident expert, providing guidance and advice for risk assessment on modulation of the immune system for therapeutics and devices, with a focus on immunogenicity. Prior to AbbVie, Dr. Gupta held various positions in pharmaceutical companies such as BMS and Eli Lilly. She earned her Ph.D. in Biochemistry/Chemistry from UNL and completed her post-doctoral training at UCI. Dr. Gupta has numerous publications in peer-reviewed journals and extensive experience in bioanalytical assays to support mechanism of action, pharmacokinetics, immunogenicity, and product release. She is actively participating in IQ consortium for TALG-Gene therapy, Cell-Therapy-oligos and contributing to in vitro method harmonization in AAPS Immunogenicity Risk Assessment community.

Disclosure information not submitted.

Presentation(s):